Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.8481
-0.0113 (-1.31%)
At close: May 19, 2026, 4:00 PM EDT
0.8568
+0.0087 (1.03%)
After-hours: May 19, 2026, 7:02 PM EDT

Heron Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
26.1228.6525.828.6815.3690.54
Short-Term Investments
18.6717.9833.4851.7369.4967.04
Cash & Short-Term Investments
44.7846.6359.2880.4184.85157.58
Cash Growth
-11.63%-21.34%-26.27%-5.24%-46.15%-24.42%
Accounts Receivable
83.6989.5978.8860.1452.0535.5
Inventory
92.5492.7553.1642.1154.5748.38
Other Current Assets
7.979.117.696.1213.9612.96
Total Current Assets
228.98238.07209.01188.77205.44254.42
Net Property, Plant & Equipment
12.0312.417.6525.629.8133.56
Other Long-Term Assets
5.215.416.488.1315.7117.72
Total Assets
246.22255.88233.15222.51250.95305.71
Accounts Payable
8.978.9911.713.243.233.8
Accrued Expenses
81.5587.176.7173.3776.4464.84
Current Portion of Leases
--3.043.082.692.42
Total Current Liabilities
90.5296.191.4679.6982.3671.06
Long-Term Debt
141.63140.64174.73173.75149.28149.08
Long-Term Leases
---2.85.58
Other Long-Term Liabilities
4.934.810.620.240.24-
Total Long-Term Liabilities
146.56145.45175.34176.79155.02157.08
Total Liabilities
237.08241.54266.8256.48237.38228.14
Preferred Stock
1.051.05----
Common Stock
1.891.881.521.51.191.02
Additional Paid-in Capital
1,9541,9511,8841,8711,8081,690
Accumulated Other Comprehensive Income
-0.0100.010.01-0.02-0.01
Retained Earnings
-1,948-1,940-1,920-1,906-1,795-1,613
Shareholders' Equity
9.1414.33-33.65-33.9713.5777.57
Total Liabilities & Equity
246.22255.88233.15222.51250.95305.71
Total Debt
141.63140.64177.76179.63157.48159.5
Net Cash (Debt)
-96.85-94.01-118.48-99.22-72.63-1.92
Net Cash Per Share
-0.55-0.56-0.78-0.72-0.67-0.02
Book Value
9.1414.33-33.65-33.9713.5777.57
Book Value Per Share
0.050.09-0.22-0.250.120.79
Tangible Book Value
9.1414.33-33.65-33.9713.5777.57
Tangible Book Value Per Share
0.050.09-0.22-0.250.120.79
Updated May 11, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q